Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

Rethinking Site Activation to Cut Startup Timelines

ByBrian Mallon,Andy Studna, Senior Editor

January 15th 2026

Extending Trial Registries for an AI-Driven Era of Patient Discovery

ByHugo Stephenson, MD

January 15th 2026

ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design

ByAndy Studna, Senior Editor

January 15th 2026

© JHVEPhoto - © JHVEPhoto - stock.adobe.com

FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials

ByAndy Studna, Senior Editor

January 14th 2026

Breaking Out of AI Pilot Mode in Clinical Development

ByLiz Beatty,Andy Studna, Senior Editor

January 14th 2026

From the Publisher

Articles in this issue

Newsletter

Related Content

Rethinking Site Activation to Cut Startup Timelines

Extending Trial Registries for an AI-Driven Era of Patient Discovery

ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design

FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials

Breaking Out of AI Pilot Mode in Clinical Development

Trending on Applied Clinical Trials Online

FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials

Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain

Breaking Out of AI Pilot Mode in Clinical Development

ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design

Extending Trial Registries for an AI-Driven Era of Patient Discovery